What's new in CGM and pumps in 2025

Diabetes technology is moving faster than ever, and much of it is now available in India. Here is what is genuinely worth knowing about.

Continuous glucose monitors (CGMs) have become smaller, cheaper, and easier to use. Modern sensors last 14–15 days, need no finger-prick calibration, and send readings straight to your phone. For many patients, two weeks of CGM data teaches more about their diabetes than years of occasional lab tests — we can see exactly how your body responds to specific meals, walks, stress, and sleep.

Insulin pumps have evolved into “hybrid closed-loop” systems. These pair a pump with a CGM and an algorithm that automatically adjusts background insulin every few minutes. For people with type 1 diabetes — and some with insulin-intensive type 2 — these systems dramatically improve time-in-range and reduce dangerous lows, especially overnight.

Connected apps and AI-assisted insights are the quiet revolution. Patterns that once took months of logbooks to spot are now surfaced automatically: dawn phenomenon, post-breakfast spikes, overnight dips.

Who benefits most? Anyone on multiple daily insulin injections, people with frequent or unaware hypoglycaemia, those with high variability, and motivated patients who want to understand their own data.

Technology is a tool, not a cure — but in the right hands it makes diabetes far more manageable. If you are curious whether a CGM or pump suits you, we can trial one in clinic and read the data together.